Been looking at the healthcare sector lately and honestly, there are some solid long-term plays if you've got $5k to deploy right now. The space underperformed overall last year, but that's actually created some interesting opportunities for buy-and-hold investors.

Let me break down three medical stocks to buy that I think deserve attention. First up is Eli Lilly. This company hit a major milestone when it became the first healthcare company to reach a trillion-dollar valuation. What's driving that? Their weight-loss portfolio is absolutely crushing it. Tirzepatide became the world's best-selling compound last year, and that's not slowing down anytime soon. They've got more coming too—an oral medication called orforglipron for diabetes and weight loss should hit the market this year. Beyond the weight-loss angle, they're investing heavily in AI and drug development. The company is literally building a supercomputer to speed up the entire drug discovery process. With $5k, you're looking at around four shares at current prices.

Then there's AbbVie. This is a different kind of medical stocks to buy story. They're the dividend powerhouse—literally part of the Dividend Kings club with 50+ consecutive years of dividend increases. Their immunology segment is carrying the load right now with drugs like Skyrizi and Rinvoq doing serious work. What impressed me most is how they handled the patent cliff when Humira lost exclusivity in 2023. They didn't panic; they pivoted. The pipeline is loaded with potential billion-dollar products coming down the line. AbbVie generates steady cash flow, which means the dividend is pretty secure. You could grab about 23 shares with $5k.

Last one is Intuitive Surgical. They own the robotic surgery space with their da Vinci system. Here's what's interesting about this medical stocks to buy pick—the switching costs are massive. Once hospitals invest in the equipment and train their surgical teams on it, switching to a competitor becomes a nightmare. That's a real competitive moat. They keep expanding their indications, which drives procedure volume and accessory sales. As the global population ages, demand for surgical procedures only goes up. The tailwinds here are pretty substantial. You could pick up nine shares at current levels.

All three of these have strong fundamentals and should deliver solid returns over the next five years if you're patient. The key is thinking long-term—these aren't quick trades, they're the kind of medical stocks to buy and forget about for a decade.